0001209191-17-041750.txt : 20170623 0001209191-17-041750.hdr.sgml : 20170623 20170623183620 ACCESSION NUMBER: 0001209191-17-041750 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170621 FILED AS OF DATE: 20170623 DATE AS OF CHANGE: 20170623 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cara Therapeutics, Inc. CENTRAL INDEX KEY: 0001346830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4 STAMFORD PLAZA STREET 2: 107 ELM STREET 9TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-406-3700 MAIL ADDRESS: STREET 1: 4 STAMFORD PLAZA STREET 2: 107 ELM STREET 9TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06902 FORMER COMPANY: FORMER CONFORMED NAME: Cara Therapeutics Inc DATE OF NAME CHANGE: 20051213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Slagel Dean CENTRAL INDEX KEY: 0001597359 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36279 FILM NUMBER: 17928637 MAIL ADDRESS: STREET 1: C/O ESPERANTE VENTURES STREET 2: PO BOX 30127 CITY: LIMHAMN STATE: V7 ZIP: SE-20061 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-21 0 0001346830 Cara Therapeutics, Inc. CARA 0001597359 Slagel Dean C/O ESPERANTE NV, SIRIUSDREEF 22 HOOFDDORP P7 2132 WT NETHERLANDS 1 0 0 0 Stock Option (Right to Buy) 19.50 2017-06-21 4 A 0 15000 0.00 A 2027-06-21 Common Stock 15000 15000 D This option was granted to the reporting person pursuant to the issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on June 21, 2018, subject to the reporting person's continued service as a director through such date. /s/Darren DeStefano, Attorney-in-Fact 2017-06-23